Ascend Capital’s Chimerix, Inc. CMRX Stock Holding History

Ascend Capital’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-699,664	Closed	-$3.24M	–	277
2017 Q4	$3.24M	Buy	699,664 +344,311	+97%	+$1.64M	0.12%	149
2017 Q3	$1.86M	Buy	+355,353	New	+$1.75M	0.07%	141

Other funds holding CMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Ascend Capital's CMRX Position: Q1 2018 in Review

Ascend Capital sold out of Chimerix, Inc. (CMRX) in Q1 2018, closing a stake of 699,664 shares — an estimated $3.24M sold.

Ascend Capital first reported a position in CMRX in Q3 2017 and held it in 2 quarters. The position peaked at $3.24M in Q4 2017. 98 funds tracked by Wall St. Rank hold CMRX as of Q1 2018.

Ascend Capital reported no remaining Chimerix, Inc. position as of Q1 2018 after selling out during the quarter.
Ascend Capital sold 699,664 Chimerix, Inc. shares in Q1 2018, an estimated $3.24M.
Ascend Capital first reported a position in Chimerix, Inc. in Q3 2017 and held it in 2 quarters.
Ascend Capital's Chimerix, Inc. position peaked at $3.24M in Q4 2017.
98 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.